Biopharmx Corp (NYSEAMERICAN:BPMX) was the target of a large decrease in short interest in the month of February. As of February 28th, there was short interest totalling 2,371,252 shares, a decrease of 0.6% from the February 15th total of 2,385,583 shares. Approximately 1.2% of the company’s shares are short sold. Based on an average daily trading volume, of 3,773,053 shares, the short-interest ratio is currently 0.6 days.

Biopharmx stock opened at $0.10 on Thursday. Biopharmx has a 1-year low of $0.05 and a 1-year high of $0.33.

WARNING: “Short Interest in Biopharmx Corp (BPMX) Decreases By 0.6%” was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this article on another domain, it was illegally stolen and republished in violation of U.S. & international copyright and trademark law. The correct version of this article can be accessed at

About Biopharmx

BioPharmX Corporation, a specialty pharmaceutical company, develops and commercializes novel prescription and over-the-counter (OTC) products that address dermatology and women's health markets. The company offers VI2OLET, an OTC molecular iodine dietary supplement that addresses cyclic breast discomfort, as well as alleviates the symptoms of fibrocystic breast condition (FBC).

Featured Article: How to calculate the annual rate of depreciation

Receive News & Ratings for Biopharmx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biopharmx and related companies with's FREE daily email newsletter.